Board Committees :: Bio-Techne Corporation (TECH)

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ og: http://ogp.me/ns# rdfs: http://www.w3.org/2000/01/rdf-schema# schema: http://schema.org/ sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema# "> <head> <meta charset="utf-8" /> <script type="text/javascript"> (window.NREUM||(NREUM={})).loader_config={licenseKey:"9dc45e1f9b",applicationID:"597140764"};window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var i=n[t]={exports:{}};e[t][0].call(i.exports,function(n){var i=e[t][1][n];return r(i||n)},i,i.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var i=0;i<t.length;i++)r(t[i]);return r}({1:[function(e,n,t){function r(){}function i(e,n,t){return function(){return o(e,[u.now()].concat(f(arguments)),n?null:this,t),n?void 0:this}}var o=e("handle"),a=e(4),f=e(5),c=e("ee").get("tracer"),u=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",d=l+"ixn-";a(p,function(e,n){s[n]=i(l+n,!0,"api")}),s.addPageAction=i(l+"addPageAction",!0),s.setCurrentRouteName=i(l+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,i="function"==typeof n;return o(d+"tracer",[u.now(),e,t],r),function(){if(c.emit((i?"":"no-")+"fn-start",[u.now(),r,i],t),i)try{return n.apply(this,arguments)}catch(e){throw c.emit("fn-err",[arguments,this,e],t),e}finally{c.emit("fn-end",[u.now()],t)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=i(d+n)}),newrelic.noticeError=function(e,n){"string"==typeof e&&(e=new Error(e)),o("err",[e,u.now(),!1,n])}},{}],2:[function(e,n,t){function r(e,n){var t=e.getEntries();t.forEach(function(e){"first-paint"===e.name?c("timing",["fp",Math.floor(e.startTime)]):"first-contentful-paint"===e.name&&c("timing",["fcp",Math.floor(e.startTime)])})}function i(e,n){var t=e.getEntries();t.length>0&&c("lcp",[t[t.length-1]])}function o(e){if(e instanceof s&&!l){var n,t=Math.round(e.timeStamp);n=t>1e12?Date.now()-t:u.now()-t,l=!0,c("timing",["fi",t,{type:e.type,fid:n}])}}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var a,f,c=e("handle"),u=e("loader"),s=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){a=new PerformanceObserver(r),f=new PerformanceObserver(i);try{a.observe({entryTypes:["paint"]}),f.observe({entryTypes:["largest-contentful-paint"]})}catch(p){}}if("addEventListener"in document){var l=!1,d=["click","keydown","mousedown","pointerdown","touchstart"];d.forEach(function(e){document.addEventListener(e,o,!1)})}}},{}],3:[function(e,n,t){function r(e,n){if(!i)return!1;if(e!==i)return!1;if(!n)return!0;if(!o)return!1;for(var t=o.split("."),r=n.split("."),a=0;a<r.length;a++)if(r[a]!==t[a])return!1;return!0}var i=null,o=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var f=navigator.userAgent,c=f.match(a);c&&f.indexOf("Chrome")===-1&&f.indexOf("Chromium")===-1&&(i="Safari",o=c[1])}n.exports={agent:i,version:o,match:r}},{}],4:[function(e,n,t){function r(e,n){var t=[],r="",o=0;for(r in e)i.call(e,r)&&(t[o]=n(r,e[r]),o+=1);return t}var i=Object.prototype.hasOwnProperty;n.exports=r},{}],5:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,i=t-n||0,o=Array(i<0?0:i);++r<i;)o[r]=e[n+r];return o}n.exports=r},{}],6:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function i(e){function n(e){return e&&e instanceof r?e:e?c(e,f,o):o()}function t(t,r,i,o){if(!l.aborted||o){e&&e(t,r,i);for(var a=n(i),f=v(t),c=f.length,u=0;u<c;u++)f[u].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function d(e,n){h[e]=v(e).concat(n)}function m(e,n){var t=h[e];if(t)for(var r=0;r<t.length;r++)t[r]===n&&t.splice(r,1)}function v(e){return h[e]||[]}function g(e){return p[e]=p[e]||i(t)}function w(e,n){u(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var h={},y={},b={on:d,addEventListener:d,removeEventListener:m,emit:t,get:g,listeners:v,context:n,buffer:w,abort:a,aborted:!1};return b}function o(){return new r}function a(){(s.api||s.feature)&&(l.aborted=!0,s=l.backlog={})}var f="nr@context",c=e("gos"),u=e(4),s={},p={},l=n.exports=i();l.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(i.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(o){}return e[n]=r,r}var i=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){i.buffer([e],r),i.emit(e,n,t)}var i=e("ee").get("handle");n.exports=r,r.ee=i},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,o,function(){return i++})}var i=1,o="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=E.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();u(y,function(n,t){e[n]||(e[n]=t)}),c("mark",["onload",a()+E.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function i(){"complete"===d.readyState&&o()}function o(){c("mark",["domContent",a()+E.offset],null,"api")}function a(){return O.exists&&performance.now?Math.round(performance.now()):(f=Math.max((new Date).getTime(),f))-E.offset}var f=(new Date).getTime(),c=e("handle"),u=e(4),s=e("ee"),p=e(3),l=window,d=l.document,m="addEventListener",v="attachEvent",g=l.XMLHttpRequest,w=g&&g.prototype;NREUM.o={ST:setTimeout,SI:l.setImmediate,CT:clearTimeout,XHR:g,REQ:l.Request,EV:l.Event,PR:l.Promise,MO:l.MutationObserver};var h=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1173.min.js"},b=g&&w&&w[m]&&!/CriOS/.test(navigator.userAgent),E=n.exports={offset:f,now:a,origin:h,features:{},xhrWrappable:b,userAgent:p};e(1),e(2),d[m]?(d[m]("DOMContentLoaded",o,!1),l[m]("load",r,!1)):(d[v]("onreadystatechange",i),l[v]("onload",r)),c("mark",["firstbyte",f],null,"api");var x=0,O=e(6)},{}],"wrap-function":[function(e,n,t){function r(e){return!(e&&e instanceof Function&&e.apply&&!e[a])}var i=e("ee"),o=e(5),a="nr@original",f=Object.prototype.hasOwnProperty,c=!1;n.exports=function(e,n){function t(e,n,t,i){function nrWrapper(){var r,a,f,c;try{a=this,r=o(arguments),f="function"==typeof t?t(r,a):t||{}}catch(u){l([u,"",[r,a,i],f])}s(n+"start",[r,a,i],f);try{return c=e.apply(a,r)}catch(p){throw s(n+"err",[r,a,p],f),p}finally{s(n+"end",[r,a,c],f)}}return r(e)?e:(n||(n=""),nrWrapper[a]=e,p(e,nrWrapper),nrWrapper)}function u(e,n,i,o){i||(i="");var a,f,c,u="-"===i.charAt(0);for(c=0;c<n.length;c++)f=n[c],a=e[f],r(a)||(e[f]=t(a,u?f+i:i,o,f))}function s(t,r,i){if(!c||n){var o=c;c=!0;try{e.emit(t,r,i,n)}catch(a){l([a,t,r,i])}c=o}}function p(e,n){if(Object.defineProperty&&Object.keys)try{var t=Object.keys(e);return t.forEach(function(t){Object.defineProperty(n,t,{get:function(){return e[t]},set:function(n){return e[t]=n,n}})}),n}catch(r){l([r])}for(var i in e)f.call(e,i)&&(n[i]=e[i]);return n}function l(n){try{e.emit("internal-error",n)}catch(t){}}return e||(e=i),t.inPlace=u,t.flag=a,t}},{}]},{},["loader"]); </script> <script> window.dataLayer = window.dataLayer || []; window.dataLayer.push({"drupalLanguage":"en","drupalCountry":"US","siteName":"Bio-Techne","brand":"R\u0026D","entityCreated":"1590009157","entityLangcode":"en","entityStatus":"1","entityUid":"66","entityUuid":"3d4b862c-a267-41b4-b42f-17c68cbcf58b","entityVid":"20511","entityName":"patrick.gray","entityType":"node","entityBundle":"page","entityId":"96","entityTitle":"Contact Us Page","userUid":0}); </script> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>Board Committees :: Bio-Techne Corporation (TECH)</title> <meta property="og:site_name" content="Bio-Techne Corporation"> <meta property="og:title" content="Board Committees :: Bio-Techne Corporation (TECH)"> <meta property="og:type" content="website"> <meta property="og:image" content="https://resources.bio-techne.com/images/Social/2019-bio-techne-logo.png"> <meta name="twitter:card" content="summary_large_image"> <meta property="og:url" content="https://investors.bio-techne.com/board-committees"> <link rel="shortcut icon" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/themes/custom/bio_techne_one/favicon.ico" type="image/vnd.microsoft.icon" /> <script src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/sites/default/files/google_tag/oneweb/google_tag.script.js%3Fqe771w" defer></script> <link rel="stylesheet" media="all" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/sites/default/files/css/css_20Bp2P_ScscocNMBFuPjOmNRM8ntgQtDT6_pRDLwR4Q.css" /> <link rel="stylesheet" media="screen" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/sites/default/files/css/css_oHJHuSFfJV7sGFxm5DuKHFG5hT9GWPYGJypoZ3AUThQ.css" /> <link rel="stylesheet" media="all" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/sites/default/files/css/css_BCp1uYpXM0to1HNKloKAPAHUtpWygt4vu0lIgNDqUuU.css" /> <link rel="stylesheet" media="all" href="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/css/bootstrap.min.css" /> <link rel="stylesheet" media="all" href="https://i.icomoon.io/public/1cf6ca2536/Tocris/style.css" /> <link rel="stylesheet" media="all" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/sites/default/files/css/css_ooDbnhcESJQAB8WksxCo7LsuJ2Flzp47aFtgX5YPslw.css" />  <link href="https://investors.bio-techne.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css" media="screen" /> <link rel="stylesheet" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/theme/css/style.css"> <script type="text/javascript" src="https://investors.bio-techne.com/javascripts/ir.js"></script> </head> <body class="ir-pg-171 page-type-board-committees pg-overview-board-committees ir html front not-logged-in no-sidebars page-node i18n-en">  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-53D2R4" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>   </div> <div class="region region-page-top"> </div> <header id="header" role="banner"> <div id="bb_container"> <div id="brands_bar"> <div class="region region-brands-bar"> <section id="block-bt-brands-bar-bt-brands-bar" class="block block-bt-brands-bar clearfix"> <li class="bb_biotechne"><a href="https://www.bio-techne.com" target="_blank" aria-label="bio-techne link" rel="noopener noreferrer"></a></li> <li class="bb_rndsystems"><a href="https://www.rndsystems.com" target="_blank" aria-label="rndsystems link" rel="noopener noreferrer"></a></li> <li class="bb_novusbio"><a href="https://www.novusbio.com" target="_blank" aria-label="novusbio link" rel="noopener noreferrer"></a></li> <li class="bb_tocris"><a href="https://www.tocris.com" target="_blank"aria-label="tocris link" rel="noopener noreferrer"></a></li> <li class="bb_proteinsimple"><a href="https://www.proteinsimple.com" target="_blank"aria-label="proteinsimple link" rel="noopener noreferrer"></a></li> <li class="bb_biospacific"><a href="https://www.biospacific.com" target="_blank"aria-label="biospacific link" rel="noopener noreferrer"></a></li> <li class="bb_cliniqa"><a href="https://www.cliniqa.com" target="_blank"aria-label="cliniqa link" rel="noopener noreferrer"></a></li> <li class="bb_acd"><a href="https://acdbio.com/" target="_blank"aria-label="acdbio link" rel="noopener noreferrer"></a></li> <li class="bb_rndheme"><a href="https://www.rndheme.com" target="_blank"aria-label="rndheme link" rel="noopener noreferrer"></a></li> </section> </div> </div> </div> <div id="hd_container"> <div id="logo_block"> <section id="block-logo-block-logo" class="block block-logo-block clearfix"> <a href="https://investors.bio-techne.com" title="https://investors.bio-techne.com" class="active"></a> </section> </div> <div id="search_bar"> <div class="region region-search-bar"> <section id="block-et-searchbar-et-searchbar-bar" class="block block-et-searchbar clearfix"> </section> </div> </div> <div id="header_info"> <div class="region region-header-info"> <section id="block-block-2" class="block block-block clearfix"> <p><a href="tel:8003437475" class="header_phone">800 343 7475</a><a href="mailto:ir@bio-techne.com" class="header_email">ir@bio-techne.com</a><a href="https://www.bio-techne.com/" target="_blank" class="header_web" ><svg xmlns="http://www.w3.org/2000/svg" height="16" viewBox="0 0 24 24" width="16"><path d="M19 19H5V5h7V3H5c-1.11 0-2 .9-2 2v14c0 1.1.89 2 2 2h14c1.1 0 2-.9 2-2v-7h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"/></svg> bio-techne.com</a></p> </section> </div> </div> <div id="ir_menu_mobile"></div> <div id="ir_menu"> <div class="region region-ir-menu"> <section id="block-menu-menu-ir-menu" class="block block-menu clearfix"> <ul class="menu nav"> <li class="first leaf"><a href="https://investors.bio-techne.com" title="">Overview</a></li> <li class="leaf"><a href="https://investors.bio-techne.com/news-events" title="">News / Events</a></li> <li class="leaf"><a href="https://investors.bio-techne.com/company-information" title="">Company Information</a></li> <li class="leaf"><a href="https://investors.bio-techne.com/strategy" title="">Strategy</a></li> <li class="leaf"><a href="https://investors.bio-techne.com/financial-information" title="">Financial Information</a></li> <li class="leaf"><a href="https://investors.bio-techne.com/stock-data" title="">Stock Data</a></li> <li class="leaf"><a href="https://investors.bio-techne.com/sec-filings" title="">SEC Filings</a></li> <li class="last leaf"><a href="https://investors.bio-techne.com/corporate-governance" title="">Corporate Governance</a></li> </ul> </section> </div> </div> </div> </header> <div class="spr-ir-container"> <div class="sub-navigation clearfix ir-navigation"> <div class="spr-ir-module-container"> <div class="container"> <a class="visible-xs mobile-sub-nav-trigger collapsed" data-toggle="collapse" data-target="#sub-navigation"> <div class="trigger-container"> <div class="meat"></div> <div class="meat"></div> <div class="meat"></div> </div> Navigation </a> <div class="sb-nav collapse clearfix" id="sub-navigation"> <ul> <h3>Corporate Governance</h3> <li> <a href="https://investors.bio-techne.com/">Overview</a> </li> <li class="expand dropdwn has-children" > <a class="" href="https://investors.bio-techne.com/news-events">News / Events</a> <ul id="spr-pages-0" class="dropdown-menu"> <li> <a href="https://investors.bio-techne.com/news-events">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/press-releases">Press Releases</a> </li> <li> <a href="https://investors.bio-techne.com/ir-calendar">IR Calendar</a> </li> <li> <a href="https://investors.bio-techne.com/email-alerts">Email Alerts</a> </li> </ul> </li> <li class="expand dropdwn has-children" > <a class="" href="https://investors.bio-techne.com/company-information">Company Info</a> <ul id="spr-pages-1" class="dropdown-menu"> <li> <a href="https://investors.bio-techne.com/company-information">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/profile">Profile</a> </li> <li> <a href="https://investors.bio-techne.com/presentations">Presentations</a> </li> <li> <a href="https://investors.bio-techne.com/management-team">Management Team</a> </li> <li> <a href="https://investors.bio-techne.com/contacts">Contacts</a> </li> <li> <a href="https://investors.bio-techne.com/faq">FAQ</a> </li> </ul> </li> <li class="expand dropdwn has-children" > <a class="" href="https://investors.bio-techne.com/financial-information">Financial Info</a> <ul id="spr-pages-2" class="dropdown-menu"> <li> <a href="https://investors.bio-techne.com/financial-information">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/balance-sheet">Balance Sheet</a> </li> <li> <a href="https://investors.bio-techne.com/income-statement">Income Statement</a> </li> <li> <a href="https://investors.bio-techne.com/cash-flow">Cash Flow</a> </li> <li> <a href="https://investors.bio-techne.com/financial-results">Financial Results</a> </li> <li> <a href="https://investors.bio-techne.com/annual-reports">Annual Reports</a> </li> </ul> </li> <li class="expand dropdwn has-children" > <a class="" href="https://investors.bio-techne.com/stock-data">Stock Data</a> <ul id="spr-pages-3" class="dropdown-menu"> <li> <a href="https://investors.bio-techne.com/stock-data">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/quote">Quote</a> </li> <li> <a href="https://investors.bio-techne.com/charts">Charts</a> </li> <li> <a href="https://investors.bio-techne.com/historical-data">Historical Data</a> </li> </ul> </li> <li class="expand dropdwn has-children" > <a class="" href="https://investors.bio-techne.com/sec-filings">SEC Filings</a> <ul id="spr-pages-4" class="dropdown-menu"> <li> <a href="https://investors.bio-techne.com/sec-filings">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/all-sec-filings">All SEC Filings</a> </li> <li> <a href="https://investors.bio-techne.com/10k-filings">10-K Filings</a> </li> <li> <a href="https://investors.bio-techne.com/quarterly-reports">Quarterly Reports</a> </li> <li> <a href="https://investors.bio-techne.com/section-16-filings">Section 16 Filings</a> </li> </ul> </li> <li class="active has-children" > <a class="" href="https://investors.bio-techne.com/corporate-governance"> Governance</a> <ul id="spr-pages-5" class="dropdown-menu"> <li> <a href="https://investors.bio-techne.com/corporate-governance">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/board-of-directors">Board of Directors</a> </li> <li class="active"> <a href="https://investors.bio-techne.com/board-committees" class="current">Board Committees</a> </li> <li> <a href="https://investors.bio-techne.com/governance-docs">Governance Documents</a> </li> </ul> </li> </ul> </div> </div> </div> </div> </div> <div class="clear"></div> <div class="spr-ir-container"> <div class="page-banner overlay" style="background: url(https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/theme/images/ir-pagebanner.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;"> <div class="container"> <div class="vertical-align"> <div class="wrapper text"> <div class="row"> <div class="col-md-10 col-md-offset-1"> <h1>Board Committees</h1> </div> </div> </div> </div> </div> </div> <div class="container"> <div class="row"> <div class="col-md-3 sidebar-nav"> <div id="tertiary-navigation"> <ul> <li class="sidebar-title"><h3>Corporate Governance</h3></li> <li> <a href="https://investors.bio-techne.com/corporate-governance">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/board-of-directors">Board of Directors</a> </li> <li class="active"> <a href="https://investors.bio-techne.com/board-committees">Board Committees</a> </li> <li> <a href="https://investors.bio-techne.com/governance-docs">Governance Documents</a> </li> </ul> </div> </div> <div class="col-md-9"> <div class="main-content"> <table class="content-table committee-list"> <thead> <tr> <th class="col-title">Audit Committee</th> <th class="col-role">Position</th> </tr> </thead> <tbody> <tr> <td class="col-title"> <p class="name">John L. Higgins</p> <div id="audit-committee-john-l-higgins" class="member-bio collapse"> <p>John L. Higgins has served on the Company's Board since 2009. Mr. Higgins has been President and Chief Executive Officer of Ligand Pharmaceuticals, Inc. since January 2007 and has been a member of Ligand's Board of Directors since March 2007. From 1997 until joining Ligand, Mr. Higgins was with Connetics Corporation, a specialty pharmaceutical company, as its Chief Financial Officer, and also served as Executive Vice President, Finance and Administration and Corporate Development at Connetics from January 2002 until its acquisition by Stiefel Laboratories, Inc. in December 2006. Mr. Higgins was previously a member of the executive management team and a director at BioCryst Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Higgins also serves as Chairman of CoMentis, Inc., a biopharmaceutical company, and has served as a director of numerous public and private companies.</p> </div> <p class="bio-link"><a data-target="#audit-committee-john-l-higgins" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle chair"></span> <span class="role-label">Chair</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Robert V. Baumgartner</p> <div id="audit-committee-robert-v-baumgartner" class="member-bio collapse"> <p>Mr. Baumgartner has served on the Company's Board since 2003 and as Chairman since 2012. Until July of 2019, Mr. Baumgartner served as Executive Chairman, Director of the Center for Diagnostic Imaging, Inc., an operator of diagnostic imaging centers. Until August, 2015, Mr. Baumgartner also served as Chief Executive Officer of that company. Prior to 2001, he held numerous executive positions, including as Chief Executive Officer and Director of American Coating International, President and Chief Executive Officer of First Solar and President of the Apogee Glass Group. He began his professional career at KPMG LLC, an international accounting firm. Mr. Baumgartner currently serves on the board of Carestream Health, Inc.</p> </div> <p class="bio-link"><a data-target="#audit-committee-robert-v-baumgartner" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Julie L. Bushman</p> <div id="audit-committee-julie-l-bushman" class="member-bio collapse"> <p>Bushman is the former Executive Vice President of International Operations for 3M. She previously served in various executive positions at 3M, including as Senior Vice President of Business Transformation and Information Technology; Executive Vice President of Safety, Security and Protection Services; Executive Vice President of Safety and Graphics; Division Vice President of the Occupational Health and Environmental Safety Division; and Chief Information Officer. Bushman joined 3M in 1983.</p> <p><span>Bushman currently serves as a director of Adient plc, an automotive seating company and Phillips 66, an energy manufacturing and logistics company</span>. She previously served as a director of Johnson Controls from 2012 through 2016.</p> </div> <p class="bio-link"><a data-target="#audit-committee-julie-l-bushman" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr class="js-same-height-row"> <td class="col-title js-same-height"> <p class="title">Audit Committee Charter</p> </td> <td class="committee-role js-same-height"> <a class="btn" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/db/319/2137/file/Bio-Techne+Audit+Committee+Charter+%28April+2024%29.pdf" target="_blank">Download</a> </td> </tr> <tbody> </table> <table class="content-table committee-list"> <thead> <tr> <th class="col-title">Nominations and Governance Committee</th> <th class="col-role">Position</th> </tr> </thead> <tbody> <tr> <td class="col-title"> <p class="name">Robert V. Baumgartner</p> <div id="nominations-and-governance-committee-robert-v-baumgartner" class="member-bio collapse"> <p>Mr. Baumgartner has served on the Company's Board since 2003 and as Chairman since 2012. Until July of 2019, Mr. Baumgartner served as Executive Chairman, Director of the Center for Diagnostic Imaging, Inc., an operator of diagnostic imaging centers. Until August, 2015, Mr. Baumgartner also served as Chief Executive Officer of that company. Prior to 2001, he held numerous executive positions, including as Chief Executive Officer and Director of American Coating International, President and Chief Executive Officer of First Solar and President of the Apogee Glass Group. He began his professional career at KPMG LLC, an international accounting firm. Mr. Baumgartner currently serves on the board of Carestream Health, Inc.</p> </div> <p class="bio-link"><a data-target="#nominations-and-governance-committee-robert-v-baumgartner" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle chair"></span> <span class="role-label">Chair</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">John L. Higgins</p> <div id="nominations-and-governance-committee-john-l-higgins" class="member-bio collapse"> <p>John L. Higgins has served on the Company's Board since 2009. Mr. Higgins has been President and Chief Executive Officer of Ligand Pharmaceuticals, Inc. since January 2007 and has been a member of Ligand's Board of Directors since March 2007. From 1997 until joining Ligand, Mr. Higgins was with Connetics Corporation, a specialty pharmaceutical company, as its Chief Financial Officer, and also served as Executive Vice President, Finance and Administration and Corporate Development at Connetics from January 2002 until its acquisition by Stiefel Laboratories, Inc. in December 2006. Mr. Higgins was previously a member of the executive management team and a director at BioCryst Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Higgins also serves as Chairman of CoMentis, Inc., a biopharmaceutical company, and has served as a director of numerous public and private companies.</p> </div> <p class="bio-link"><a data-target="#nominations-and-governance-committee-john-l-higgins" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Alpna Seth, Ph.D.</p> <div id="nominations-and-governance-committee-alpna-seth-ph-d" class="member-bio collapse"> <p><span>Dr. Alpna Seth formerly served as President and</span> Chief Executive Officer of Nura Bio, a venture capital funded biotech company focused on novel therapeutics for serious neurodegenerative diseases spanning central, peripheral and ocular nervous systems. The company is headquartered in South San Francisco.  Previously, Dr. Seth was Chief Operating Officer of Vir Biotechnology, Inc.  Prior to joining Vir in July 2017, Dr. Seth was Senior Vice President and Global head of the Biosimilars business for Biogen, Inc. headquartered in Zug, Switzerland since 2014.  <span>For the period from 1998 through 2014, Dr. Seth held a range of executive roles at Biogen in business development, drug development and marketing programs</span>.  She holds a Ph.D. in Biochemistry and Molecular Biology from University of Massachusetts Medical School. Dr. Seth brings a breadth of experience in drug discovery, marketing, international operations and business development.  Among other attributes, skills and qualifications, the Board believes Dr. Seth鈥檚 extensive background in the pharmaceutical industry and her deep knowledge of critical areas of science provide a valuable strategic perspective for our business generally and for a key customer group for the Company.</p> </div> <p class="bio-link"><a data-target="#nominations-and-governance-committee-alpna-seth-ph-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr class="js-same-height-row"> <td class="col-title js-same-height"> <p class="title">Nominations and Governance Committee Charter</p> </td> <td class="committee-role js-same-height"> <a class="btn" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/db/319/2139/file/Bio-Techne+Nominations+and+Governance+Committee+Charter.pdf" target="_blank">Download</a> </td> </tr> <tbody> </table> <table class="content-table committee-list"> <thead> <tr> <th class="col-title">Compensation Committee</th> <th class="col-role">Position</th> </tr> </thead> <tbody> <tr> <td class="col-title"> <p class="name">Julie L. Bushman</p> <div id="compensation-committee-julie-l-bushman" class="member-bio collapse"> <p>Bushman is the former Executive Vice President of International Operations for 3M. She previously served in various executive positions at 3M, including as Senior Vice President of Business Transformation and Information Technology; Executive Vice President of Safety, Security and Protection Services; Executive Vice President of Safety and Graphics; Division Vice President of the Occupational Health and Environmental Safety Division; and Chief Information Officer. Bushman joined 3M in 1983.</p> <p><span>Bushman currently serves as a director of Adient plc, an automotive seating company and Phillips 66, an energy manufacturing and logistics company</span>. She previously served as a director of Johnson Controls from 2012 through 2016.</p> </div> <p class="bio-link"><a data-target="#compensation-committee-julie-l-bushman" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle chair"></span> <span class="role-label">Chair</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Joseph D. Keegan, Ph.D.</p> <div id="compensation-committee-joseph-d-keegan-ph-d" class="member-bio collapse"> <p>Dr. Joseph Keegan currently serves as a director and advisor for <span>Interpace </span>Biosciences (Nasdaq: IDXG) as well as a number of <span>privately held life science companies, including executive director at Carterra, Inc., and director at Nanomedical Diagnostics</span>. From 2007 until its sale to Pall Corporation in 2012, Dr. Keegan served as President and Chief Executive Officer of ForteBio, Inc. Dr. Keegan joined ForteBio from Molecular Devices Corporation, where he served as President and Chief Executive Officer from 1998 to 2007. Prior to Molecular Devices, Dr. Keegan held leadership positions at Becton Dickinson, Leica, Inc. and GE Medical Systems. He has also served on numerous public and private company boards of life science tools companies. Dr. Keegan holds a Ph.D. in Physical Chemistry from Stanford University. Among other attributes, skills and qualifications, the Board believes Dr. Keegan is qualified to serve as a Director of the Company because of his deep knowledge of our industry and customers, as well as his extensive executive management experience and prior service on other private and public company boards.</p> </div> <p class="bio-link"><a data-target="#compensation-committee-joseph-d-keegan-ph-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Randolph C. Steer, M.D., Ph.D.</p> <div id="compensation-committee-randolph-c-steer-m-d-ph-d" class="member-bio collapse"> <p>Randolph C. Steer, M.D., Ph.D., has served on the Company's Board since 1990. Dr. Steer is currently an independent biotechnology consultant. He served as President and Chief Operating Officer of Capstone Therapeutics Corp. from April 2006 to October 2011. Dr. Steer was elected to the Mayo Clinic Board of Trustees in November 2011. In the past five years, Dr. Steer also served as a director of Vital Therapies, Inc. From 1989 to 2006 Dr. Steer was a consultant to the pharmaceutical and biotechnology industries, where he advised companies in business development, medical marketing and regulatory and clinical affairs. His prior experience includes service as Associate Director of Medical Affairs at Marion Laboratories and as Medical Director at Ciba Consumer Pharmaceuticals.</p> </div> <p class="bio-link"><a data-target="#compensation-committee-randolph-c-steer-m-d-ph-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Dr. Rupert Vessey</p> <div id="compensation-committee-dr-rupert-vessey" class="member-bio collapse"> <p><span>Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently Executive Partner and Chief Scientist at Flagship Pioneering.  Previously, Dr. Vessey was the President of Global Research and Early Development at Bristol-Myers Squibb, a position he also held at Celgene prior to its acquisition by Bristol-Myers Squibb.  Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Prior to his ten years at Merck, Dr. Vessey worked in drug discovery, experimental medicine, and early clinical development at GlaxoSmithKline. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK. </span></p> </div> <p class="bio-link"><a data-target="#compensation-committee-dr-rupert-vessey" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr class="js-same-height-row"> <td class="col-title js-same-height"> <p class="title">Compensation Committee Charter</p> </td> <td class="committee-role js-same-height"> <a class="btn" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/db/319/2138/file/Bio-Techne+Compensation+Committee+Charter+%28July+2021%29.pdf" target="_blank">Download</a> </td> </tr> <tbody> </table> <table class="content-table committee-list"> <thead> <tr> <th class="col-title">Science and Technology Committee</th> <th class="col-role">Position</th> </tr> </thead> <tbody> <tr> <td class="col-title"> <p class="name">Roeland Nusse, Ph.D.</p> <div id="science-and-technology-committee-roeland-nusse-ph-d" class="member-bio collapse"> <p>Roeland Nusse, Ph.D., has served on the Company's Board since May 2010. Dr. Nusse has served as Chairman of the Department of Developmental Biology at Stanford University since 2007. Dr. Nusse has been a professor or associate professor in the Department of Developmental Biology at Stanford University and an investigator at the Howard Hughes Medical Institute since 1990. He has also been the chair of the Department of Developmental Biology at Stanford since 2007. Dr. Nusse was previously at the Netherlands Cancer Institute (Amsterdam, The Netherlands) as a staff scientist and ultimately head of the Department of Molecular Biology. Dr. Nusse was elected to the United States National Academy of Sciences in April 2010. Dr. Nusse was previously named a member of the European Molecular Biology Organization in 1988, a member of the Royal Dutch Academy of Sciences in 1997 and a member of the American Academy of Arts and Sciences in 2001.</p> </div> <p class="bio-link"><a data-target="#science-and-technology-committee-roeland-nusse-ph-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle chair"></span> <span class="role-label">Chair</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Judith Klimovsky, M.D.</p> <div id="science-and-technology-committee-judith-klimovsky-m-d" class="member-bio collapse"> <p><span>Dr. Klimovsky has served on the Company鈥檚 Board of Directors since 2024. Dr. Klimovsky is currently the Executive Vice President and Chief Development Officer at Genmab, an international biotechnology company specialized in the creation and development of antibody therapeutics. Before joining Genmab in 2017, Dr. Klimovsky held various senior global clinical and research positions at Novartis Oncology, a division of Novartis AG, including SVP & Global Head, Oncology Clinical Development. Dr. Klimovsky also served as Regional Medical Director, Latin America for Merck & Co. and held several research and development roles of increasing responsibility at Bristol-Myers Squibb Company. Dr. Klimovsky received her M.D. from the Universidad de Buenos Aires.</span></p> </div> <p class="bio-link"><a data-target="#science-and-technology-committee-judith-klimovsky-m-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Alpna Seth, Ph.D.</p> <div id="science-and-technology-committee-alpna-seth-ph-d" class="member-bio collapse"> <p><span>Dr. Alpna Seth formerly served as President and</span> Chief Executive Officer of Nura Bio, a venture capital funded biotech company focused on novel therapeutics for serious neurodegenerative diseases spanning central, peripheral and ocular nervous systems. The company is headquartered in South San Francisco.  Previously, Dr. Seth was Chief Operating Officer of Vir Biotechnology, Inc.  Prior to joining Vir in July 2017, Dr. Seth was Senior Vice President and Global head of the Biosimilars business for Biogen, Inc. headquartered in Zug, Switzerland since 2014.  <span>For the period from 1998 through 2014, Dr. Seth held a range of executive roles at Biogen in business development, drug development and marketing programs</span>.  She holds a Ph.D. in Biochemistry and Molecular Biology from University of Massachusetts Medical School. Dr. Seth brings a breadth of experience in drug discovery, marketing, international operations and business development.  Among other attributes, skills and qualifications, the Board believes Dr. Seth鈥檚 extensive background in the pharmaceutical industry and her deep knowledge of critical areas of science provide a valuable strategic perspective for our business generally and for a key customer group for the Company.</p> </div> <p class="bio-link"><a data-target="#science-and-technology-committee-alpna-seth-ph-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Randolph C. Steer, M.D., Ph.D.</p> <div id="science-and-technology-committee-randolph-c-steer-m-d-ph-d" class="member-bio collapse"> <p>Randolph C. Steer, M.D., Ph.D., has served on the Company's Board since 1990. Dr. Steer is currently an independent biotechnology consultant. He served as President and Chief Operating Officer of Capstone Therapeutics Corp. from April 2006 to October 2011. Dr. Steer was elected to the Mayo Clinic Board of Trustees in November 2011. In the past five years, Dr. Steer also served as a director of Vital Therapies, Inc. From 1989 to 2006 Dr. Steer was a consultant to the pharmaceutical and biotechnology industries, where he advised companies in business development, medical marketing and regulatory and clinical affairs. His prior experience includes service as Associate Director of Medical Affairs at Marion Laboratories and as Medical Director at Ciba Consumer Pharmaceuticals.</p> </div> <p class="bio-link"><a data-target="#science-and-technology-committee-randolph-c-steer-m-d-ph-d" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr> <td class="col-title"> <p class="name">Dr. Rupert Vessey</p> <div id="science-and-technology-committee-dr-rupert-vessey" class="member-bio collapse"> <p><span>Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently Executive Partner and Chief Scientist at Flagship Pioneering.  Previously, Dr. Vessey was the President of Global Research and Early Development at Bristol-Myers Squibb, a position he also held at Celgene prior to its acquisition by Bristol-Myers Squibb.  Before joining Celgene, Dr. Vessey held various research and development senior management positions at Merck. Prior to his ten years at Merck, Dr. Vessey worked in drug discovery, experimental medicine, and early clinical development at GlaxoSmithKline. Dr. Vessey holds an MA in physiological sciences and a BM BCh in clinical medicine from Oxford University where he completed his DPhil at the Institute for Molecular Medicine, Oxford along with additional clinical training at various hospitals in the UK. He is a member of the Royal College of Physicians of London UK. </span></p> </div> <p class="bio-link"><a data-target="#science-and-technology-committee-dr-rupert-vessey" data-toggle="collapse" href="javascript:void(0)" class="block-link" href="#"><span class="view">View</span> Bio</a></p> </td> <td class="col-role"><div class="committee-role"><span class="role-circle member"></span> <span class="role-label">Member</span></div></td> </tr> <tr class="js-same-height-row"> <td class="col-title js-same-height"> <p class="title">Science and Technology Committee Charter</p> </td> <td class="committee-role js-same-height"> <a class="btn" href="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/db/319/2243/file/Bio-Techne+Science+and+Technology+Committee+Charter.pdf" target="_blank">Download</a> </td> </tr> <tbody> </table> </div> </div> </div> </div> </div> <div class="spr-ir-container"> <div class="module-quick-links"> <ul> <li><a href="https://investors.bio-techne.com/email-alerts" class="email">Email Alerts</a></li> <li><a href="https://investors.bio-techne.com/contacts" class="contacts">Contacts</a></li> <li><a href="https://investors.bio-techne.com/rss" class="rss" target="_blank">RSS News Feed</a></li> </ul> </div> </div> <div id="site-footer__top" class=""> <footer> <div class="container"> <div class="row"> <div class="col-md-3"> <div> <div id="block-footercolumn1"> <div> <img class="lazyload logo" data-src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/sites/default/files/2020-07/Bio-Techne_Logo-White.svg" width="150" height="27" alt="Bio-Techne" typeof="foaf:Image" /> </div> <div> <p>614 McKinley Place NE<br /> Minneapolis, MN 55413<br /> USA </p> <p>TEL 612 379 2956<br /> Toll-free 800 343 7475<br /> FAX 612 656 4400 </p> </div> </div> </div> </div> <div class="col-md-3"> <div> <nav role="navigation" aria-labelledby="block-footercolumn2-menu" id="block-footercolumn2"> <h4 id="block-footercolumn2-menu">Who We Are</h4> <ul> <li> <a href="https://www.bio-techne.com/about/about-bio-techne" title="About Bio-Techne" data-drupal-link-system-path="node/16">About Bio-Techne</a> </li> <li> <a href="https://www.bio-techne.com/brands" title="Brands" data-drupal-link-system-path="node/46">Bio-Techne Brands</a> </li> <li> <a href="https://www.bio-techne.com/about/careers" title="History" data-drupal-link-system-path="node/21">Careers </a> </li> <li> <a href="https://www.bio-techne.com/about/corporate-and-social-responsibility" title="Corporate Responsibility" data-drupal-link-system-path="node/61">Corporate & Social Responsibility </a> </li> <li> <a href="https://www.bio-techne.com/terms-and-conditions" data-drupal-link-system-path="node/686">Terms and Conditions</a> </li> </ul> </nav> </div> </div> <div class="col-md-3"> <div> <nav role="navigation" aria-labelledby="block-footercolumn3-menu" id="block-footercolumn3"> <h4 id="block-footercolumn3-menu">Investor Relations</h4> <ul> <li> <a href="https://investors.bio-techne.com/" title="Overview">Overview</a> </li> <li> <a href="https://investors.bio-techne.com/news-events" title="News/Events">News / Events</a> </li> <li> <a href="https://investors.bio-techne.com/company-information" title="Company Information">Company Information</a> </li> <li> <a href="https://investors.bio-techne.com/financial-information" title="Financial Information">Financial Information</a> </li> <li> <a href="https://investors.bio-techne.com/stock-data" title="Stock Data">Stock Data</a> </li> <li> <a href="https://investors.bio-techne.com/sec-filings" title="SEC Filings">SEC Filings</a> </li> <li> <a href="https://investors.bio-techne.com/corporate-governance" title="Corporate Governance">Corporate Governance</a> </li> </ul> </nav> </div> </div> <div class="col-md-3"> <div> <div id="block-stayconnectedblock"> <div> <div> <h4>Stay Connected</h4> <ul> <li> <a href="https://www.facebook.com/BioTechne/" target="_blank" rel="noopener noreferrer"> <img alt="Facebook" class="social-icon lazyload" data-src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/themes/custom/bio_techne_global/images/icon_social_facebook.svg" /></a> <a href="https://twitter.com/biotechne" target="_blank" rel="noopener noreferrer"> <img alt="Twitter" class="social-icon lazyload" data-src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/themes/custom/bio_techne_global/images/icon_social_twitter.svg" /></a> <a href="https://www.linkedin.com/company/bio-techne" target="_blank" rel="noopener noreferrer"> <img alt="LinkedIn" class="social-icon lazyload" data-src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/themes/custom/bio_techne_global/images/icon_social_linkedin.svg" /></a> <a href="https://www.youtube.com/channel/UCCE68f793S1eyQM2E1BH0Bw?reload=9" target="_blank" rel="noopener noreferrer"> <img alt="YouTube" class="social-icon lazyload" data-src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/themes/custom/bio_techne_global/images/icon_social_youtube.svg" /></a> <a href="https://www.instagram.com/bio_techne/" target="_blank" rel="noopener noreferrer"> <img alt="Instagram" class="social-icon lazyload" data-src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/site-files/20200806/themes/custom/bio_techne_global/images/icon_social_instagram.svg" /></a> </li> <li><a data-drupal-link-system-path="node/96" href="https://www.bio-techne.com/support/contact-us/" title="Contact Us" class="is-active">Contact Us</a></li> </ul> </div> </div> </div> </div> </div> </div> </div> </footer> </div> <div id="site-footer__bottom" class=""> <div class="container"> <div class="row"> <div class="col-md-12"> <div> <nav role="navigation" aria-labelledby="block-utilityfootermenu-menu" id="block-utilityfootermenu"> <h4 class="visually-hidden" id="block-utilityfootermenu-menu">Utility Footer Menu</h4> <ul> <li> <a href="https://www.bio-techne.com/privacy-and-cookie-policy" title="Privacy and Cookie Policy" data-drupal-link-system-path="node/681">Privacy and Cookie Policy</a> </li> <li> <a href="https://www.bio-techne.com/sitemap.xml" title="Site Map" data-drupal-link-system-path="sitemap.xml">Site Map</a> </li> <li> <span>漏 Copyright 2024 Bio-Techne. All Rights Reserved.</span> </li> </ul> </nav> </div> </div> </div> </div> </div> <script> var asset_url = 'https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne'; var website_base_url = 'https://www.bio-techne.com'; var ir_base_url = 'https://investors.bio-techne.com'; var hCaptchaSiteKey = '778a5748-d323-4b73-a06c-9625642de8bc'; </script> <script src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/theme/js/_js/all.js"></script> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/96","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"bio_techne_global\/bootstrap_cdn,bio_techne_global\/global-styling,bio_techne_global\/icomoon,biotechne_live_agent\/biotechne-live-agent-library,bloomreach_pixel\/datalayer-pusher,commerce\/commerce-global,core\/html5shiv,datalayer\/behaviors,distributor\/distributor-contact-block,internationalization\/biotechne-i18n,paragraphs\/drupal.paragraphs.unpublished,product_search\/search_bar,responsive_table_filter\/responsive-table,system\/base","theme":"bio_techne_global","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true},"dataLayer":{"defaultLang":"en","languages":{"en":{"id":"en","name":"English","direction":"ltr","weight":0}}},"internationalization":{"origin":{"id":"us","label":"US","country_name":"United States","alternate_spellings":"US USA","country_enabled":true,"commerce_enabled":true,"region":"North America","currency":"USD","localities":"[{\u0022text\u0022:\u0022Delaware\u0022,\u0022value\u0022:\u0022DE\u0022},{\u0022text\u0022:\u0022Hawaii\u0022,\u0022value\u0022:\u0022HI\u0022},{\u0022text\u0022:\u0022Puerto Rico\u0022,\u0022value\u0022:\u0022PR\u0022},{\u0022text\u0022:\u0022Texas\u0022,\u0022value\u0022:\u0022TX\u0022},{\u0022text\u0022:\u0022Palau\u0022,\u0022value\u0022:\u0022PW\u0022},{\u0022text\u0022:\u0022Massachusetts\u0022,\u0022value\u0022:\u0022MA\u0022},{\u0022text\u0022:\u0022Maryland\u0022,\u0022value\u0022:\u0022MD\u0022},{\u0022text\u0022:\u0022Maine\u0022,\u0022value\u0022:\u0022ME\u0022},{\u0022text\u0022:\u0022Iowa\u0022,\u0022value\u0022:\u0022IA\u0022},{\u0022text\u0022:\u0022Marshall Islands\u0022,\u0022value\u0022:\u0022MH\u0022},{\u0022text\u0022:\u0022Idaho\u0022,\u0022value\u0022:\u0022ID\u0022},{\u0022text\u0022:\u0022Michigan\u0022,\u0022value\u0022:\u0022MI\u0022},{\u0022text\u0022:\u0022Utah\u0022,\u0022value\u0022:\u0022UT\u0022},{\u0022text\u0022:\u0022Armed Forces (AA)\u0022,\u0022value\u0022:\u0022AA\u0022},{\u0022text\u0022:\u0022Minnesota\u0022,\u0022value\u0022:\u0022MN\u0022},{\u0022text\u0022:\u0022Missouri\u0022,\u0022value\u0022:\u0022MO\u0022},{\u0022text\u0022:\u0022Northern Mariana Islands\u0022,\u0022value\u0022:\u0022MP\u0022},{\u0022text\u0022:\u0022Illinois\u0022,\u0022value\u0022:\u0022IL\u0022},{\u0022text\u0022:\u0022Armed Forces (AE)\u0022,\u0022value\u0022:\u0022AE\u0022},{\u0022text\u0022:\u0022Indiana\u0022,\u0022value\u0022:\u0022IN\u0022},{\u0022text\u0022:\u0022Mississippi\u0022,\u0022value\u0022:\u0022MS\u0022},{\u0022text\u0022:\u0022Montana\u0022,\u0022value\u0022:\u0022MT\u0022},{\u0022text\u0022:\u0022Alaska\u0022,\u0022value\u0022:\u0022AK\u0022},{\u0022text\u0022:\u0022Virginia\u0022,\u0022value\u0022:\u0022VA\u0022},{\u0022text\u0022:\u0022Alabama\u0022,\u0022value\u0022:\u0022AL\u0022},{\u0022text\u0022:\u0022Armed Forces (AP)\u0022,\u0022value\u0022:\u0022AP\u0022},{\u0022text\u0022:\u0022Arkansas\u0022,\u0022value\u0022:\u0022AR\u0022},{\u0022text\u0022:\u0022American Samoa\u0022,\u0022value\u0022:\u0022AS\u0022},{\u0022text\u0022:\u0022Virgin Islands\u0022,\u0022value\u0022:\u0022VI\u0022},{\u0022text\u0022:\u0022North Carolina\u0022,\u0022value\u0022:\u0022NC\u0022},{\u0022text\u0022:\u0022North Dakota\u0022,\u0022value\u0022:\u0022ND\u0022},{\u0022text\u0022:\u0022Rhode Island\u0022,\u0022value\u0022:\u0022RI\u0022},{\u0022text\u0022:\u0022Nebraska\u0022,\u0022value\u0022:\u0022NE\u0022},{\u0022text\u0022:\u0022Arizona\u0022,\u0022value\u0022:\u0022AZ\u0022},{\u0022text\u0022:\u0022New Hampshire\u0022,\u0022value\u0022:\u0022NH\u0022},{\u0022text\u0022:\u0022New Jersey\u0022,\u0022value\u0022:\u0022NJ\u0022},{\u0022text\u0022:\u0022Vermont\u0022,\u0022value\u0022:\u0022VT\u0022},{\u0022text\u0022:\u0022New Mexico\u0022,\u0022value\u0022:\u0022NM\u0022},{\u0022text\u0022:\u0022Florida\u0022,\u0022value\u0022:\u0022FL\u0022},{\u0022text\u0022:\u0022Micronesia\u0022,\u0022value\u0022:\u0022FM\u0022},{\u0022text\u0022:\u0022Nevada\u0022,\u0022value\u0022:\u0022NV\u0022},{\u0022text\u0022:\u0022Washington\u0022,\u0022value\u0022:\u0022WA\u0022},{\u0022text\u0022:\u0022New York\u0022,\u0022value\u0022:\u0022NY\u0022},{\u0022text\u0022:\u0022South Carolina\u0022,\u0022value\u0022:\u0022SC\u0022},{\u0022text\u0022:\u0022South Dakota\u0022,\u0022value\u0022:\u0022SD\u0022},{\u0022text\u0022:\u0022Wisconsin\u0022,\u0022value\u0022:\u0022WI\u0022},{\u0022text\u0022:\u0022Ohio\u0022,\u0022value\u0022:\u0022OH\u0022},{\u0022text\u0022:\u0022Georgia\u0022,\u0022value\u0022:\u0022GA\u0022},{\u0022text\u0022:\u0022Oklahoma\u0022,\u0022value\u0022:\u0022OK\u0022},{\u0022text\u0022:\u0022California\u0022,\u0022value\u0022:\u0022CA\u0022},{\u0022text\u0022:\u0022West Virginia\u0022,\u0022value\u0022:\u0022WV\u0022},{\u0022text\u0022:\u0022Wyoming\u0022,\u0022value\u0022:\u0022WY\u0022},{\u0022text\u0022:\u0022Oregon\u0022,\u0022value\u0022:\u0022OR\u0022},{\u0022text\u0022:\u0022Kansas\u0022,\u0022value\u0022:\u0022KS\u0022},{\u0022text\u0022:\u0022Colorado\u0022,\u0022value\u0022:\u0022CO\u0022},{\u0022text\u0022:\u0022Kentucky\u0022,\u0022value\u0022:\u0022KY\u0022},{\u0022text\u0022:\u0022Guam\u0022,\u0022value\u0022:\u0022GU\u0022},{\u0022text\u0022:\u0022Pennsylvania\u0022,\u0022value\u0022:\u0022PA\u0022},{\u0022text\u0022:\u0022Connecticut\u0022,\u0022value\u0022:\u0022CT\u0022},{\u0022text\u0022:\u0022Louisiana\u0022,\u0022value\u0022:\u0022LA\u0022},{\u0022text\u0022:\u0022Tennessee\u0022,\u0022value\u0022:\u0022TN\u0022},{\u0022text\u0022:\u0022District of Columbia\u0022,\u0022value\u0022:\u0022DC\u0022}]","phone_pattern":null}},"bloomreach_pixel":{"br_info":{"acct_id":"6368","domain_key":"biotechne"},"page_info":{"ptype":"other"},"order_info":{"order_id":""},"user_info":{"uid":0},"searchbar":{"enabled":"1","form":".product-search-form","input":"#edit-keywords"},"atc":{"enabled":"1","form":".add-to-cart-block"}},"user":{"uid":0,"permissionsHash":"37f688f33eb0f18edd7dffc9c7e87353691e6a5b65d0fd72fa7ccf602404c804"}}</script> <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.0.4/popper.js"></script>  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/js/bootstrap.min.js"></script> <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/js/bootstrap.bundle.min.js"></script>  <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"9dc45e1f9b","applicationID":"597140764","transactionName":"MgFWZhYCVkMEUENeCQtLdVEQCldeSndFQhYECGhcCwddbCZcWUMUCghYVxY\/dl8BVmFeAxInW1wQEVdcCVZFGlgTDVFF","queueTime":0,"applicationTime":722,"atts":"HkZVEF4YRU0=","errorBeacon":"bam.nr-data.net","agent":""}</script> <script type="text/javascript"> jq.ajax({ url: "https://investors.bio-techne.com/quote-api", dataType: 'jsonp', jsonpCallback: "populateQuoteBox", crossDomain: true }).done(function(response) { // Do nothing. }).fail(function(error) { console.log('ERROR retrieving quote: ' + error.statusText); }); </script> <script src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/theme/js/aside/_js/browser-check.min.js" async></script>  <script src="https://d1io3yog0oux5.cloudfront.net/_94c4180ded85dbf620c95735a02bc430/biotechne/files/theme/js/aside/lazyload/lazysizes.min.js"></script> </body> </html>

CINXE.COM

Board Committees :: Bio-Techne Corporation (TECH)